Literature DB >> 22223206

A second chance for a PPARγ targeted therapy?

Andrew W Norris1, Curt D Sigmund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22223206      PMCID： PMC3583552          DOI： 10.1161/RES.0b013e3182435d88

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  20 in total

1.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  Pioglitazone for diabetes prevention in impaired glucose tolerance.

Authors:  Ralph A DeFronzo; Devjit Tripathy; Dawn C Schwenke; MaryAnn Banerji; George A Bray; Thomas A Buchanan; Stephen C Clement; Robert R Henry; Howard N Hodis; Abbas E Kitabchi; Wendy J Mack; Sunder Mudaliar; Robert E Ratner; Ken Williams; Frankie B Stentz; Nicolas Musi; Peter D Reaven
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

3.  The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.

Authors:  Tsuyoshi Waku; Takuma Shiraki; Takuji Oyama; Kanako Maebara; Rinna Nakamori; Kosuke Morikawa
Journal:  EMBO J       Date:  2010-08-17       Impact factor: 11.598

4.  PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale.

Authors:  Martina I Lefterova; Yong Zhang; David J Steger; Michael Schupp; Jonathan Schug; Ana Cristancho; Dan Feng; David Zhuo; Christian J Stoeckert; X Shirley Liu; Mitchell A Lazar
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

5.  Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.

Authors:  Andreas M Beyer; Willem J de Lange; Carmen M Halabi; Mary L Modrick; Henry L Keen; Frank M Faraci; Curt D Sigmund
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

6.  Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

Authors:  Jang Hyun Choi; Alexander S Banks; Jennifer L Estall; Shingo Kajimura; Pontus Boström; Dina Laznik; Jorge L Ruas; Michael J Chalmers; Theodore M Kamenecka; Matthias Blüher; Patrick R Griffin; Bruce M Spiegelman
Journal:  Nature       Date:  2010-07-22       Impact factor: 49.962

7.  Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype.

Authors:  Michael Schupp; Ana G Cristancho; Martina I Lefterova; Elyisha A Hanniman; Erika R Briggs; David J Steger; Mohammed Qatanani; Joshua C Curtin; Jonathan Schug; Scott A Ochsner; Neil J McKenna; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

8.  Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.

Authors:  Carmen M Halabi; Andreas M Beyer; Willem J de Lange; Henry L Keen; Gary L Baumbach; Frank M Faraci; Curt D Sigmund
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

9.  Cross species comparison of C/EBPα and PPARγ profiles in mouse and human adipocytes reveals interdependent retention of binding sites.

Authors:  Søren F Schmidt; Mette Jørgensen; Yun Chen; Ronni Nielsen; Albin Sandelin; Susanne Mandrup
Journal:  BMC Genomics       Date:  2011-03-16       Impact factor: 3.969

10.  TZDs and Bone: A Review of the Recent Clinical Evidence.

Authors:  Ann V Schwartz
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964
View more
  4 in total

Review 1.  PPARγ and the global map of adipogenesis and beyond.

Authors:  Martina I Lefterova; Anders K Haakonsson; Mitchell A Lazar; Susanne Mandrup
Journal:  Trends Endocrinol Metab       Date:  2014-04-29       Impact factor: 12.015

2.  Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.

Authors:  Yi Chu; Donald D Lund; Robert M Weiss; Robert M Brooks; Hardik Doshi; Georges P Hajj; Curt D Sigmund; Donald D Heistad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 3.  Mechanisms of thrombosis in obesity.

Authors:  Ilya O Blokhin; Steven R Lentz
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

Review 4.  Role of the Peroxisome Proliferator Activated Receptors in Hypertension.

Authors:  Shi Fang; M Christine Livergood; Pablo Nakagawa; Jing Wu; Curt D Sigmund
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 23.213
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.